Crystals of the brain.

06:00 EST 27th January 2011 | BioPortfolio

Summary of "Crystals of the brain."

No Summary Available


Norwegian University of Science and Technology, Trondheim, Norway.

Journal Details

This article was published in the following journal.

Name: EMBO molecular medicine
ISSN: 1757-4684


PubMed Articles [7112 Associated PubMed Articles listed on BioPortfolio]

Aperiodic crystals and beyond.

Crystals are paradigms of ordered structures. While order was once seen as synonymous with lattice periodic arrangements, the discoveries of incommensurate crystals and quasicrystals led to a more gen...

Self-Assembly: Precisely Tailoring the Stoichiometric Stacking of Perylene-TCNQ Co-Crystals towards Different Nano and Microstructures with Varied Optoelectronic Performances (Small 18/2015).

A solution self-assembly method is reported by Y. G. Zhen, W. P. Hu, and co-workers to tailor the stoichiometric stacking of perylene-TCNQ co-crystals towards different nano/microstructures by tuning ...

Electrolytic coloration and spectral properties of O(2-)- and Mg(2+)-codoped LiF crystals.

O(2-)- and Mg(2+)-codoped (OMC) LiF crystals are colored electrolytically at various temperatures and voltages using a pointed cathode and a flat anode. F, F2, F3(+), Mg-perturbed F and Mg-perturbed F...

Fabrication of La2Ti2O7 Crystals Using an Alkali-Metal Molybdate Flux Growth Method and Their Nitridability To Form LaTiO2N Crystals under a High-Temperature NH3 Atmosphere.

Flux growth is a promising method that allows one to control over the crystalline phase, crystal shape, crystal size, and crystal surface through the selection of a suitable flux. In this work, lantha...

Photoelastic properties of NaBi(MoO4)2 crystals.

In this work we present the results of comprehensive studies of the piezo-optic and elasto-optic effects in NaBi(MoO4)2 crystals. The full matrices of the piezo-optic and elasto-optic coefficients for...

Clinical Trials [2133 Associated Clinical Trials listed on BioPortfolio]

Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis

This study will continue to evaluate the long term safety and effectiveness of cysteamine eye drops for treating cystine crystals in the corneas of patients with cystinosis. These drops a...

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

The study is a 2 arm, multi-center, randomized, open-labeled clinical trial designed to assess the effects of varying doses and schedules of oral insulin on immunological and metabolic mar...

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

This study will evaluate the safety and effectiveness of a new formulation of eye drops used to treat cystine crystals that form in the corneas of patients with cystinosis. Cystinosis is ...

Monitoring Brain Activity in Human Brain Injury

The outcome of brain injury (physical or stroke) may be related to a brain electrical phenomenon known as Cortical Spreading Depression (CSD). This is a brief cessation of function in a l...

Cases With Traumatic and Non Traumatic Brain Damage Treated in the Intensive Care

Cases of traumatic and nontraumatic brain damage have high rates of morbidity and mortality. In this study of cases being treated in the ICU for a diagnosis of brain damage, it was aimed t...

Medical and Biotech [MESH] Definitions

Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.

Bleeding within the brain as a result of penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA. Traumatically induced hemorrhages may occur in any area of the brain, including the CEREBRUM; BRAIN STEM (see BRAIN STEM HEMORRHAGE, TRAUMATIC); and CEREBELLUM.

A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.